Literature DB >> 19124411

Capillary rarefaction in treated and untreated hypertensive subjects.

Cynthia Cheng1, Constantine Daskalakis, Bonita Falkner.   

Abstract

This study aimed to determine if capillary rarefaction is detectable and associated with endothelial dysfunction in persons with mild systolic blood pressure (SBP) elevation. Capillary density and endothelial function were quantified for 150 nondiabetic participants, grouped by blood pressure (BP) as normotensive, untreated high BP, and treated high BP. Structural capillary rarefaction measures were not different between the three groups. Functional capillary rarefaction measures were significantly lower in both high BP groups compared to normotensives, and correlated inversely with endothelial function. The study findings indicate that the hypertensive vascular pathologic process is already underway at modest levels of blood pressure elevation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19124411      PMCID: PMC2697846          DOI: 10.1177/1753944708089696

Source DB:  PubMed          Journal:  Ther Adv Cardiovasc Dis        ISSN: 1753-9447


  43 in total

Review 1.  Testing for endothelial dysfunction.

Authors:  O T Raitakari; D S Celermajer
Journal:  Ann Med       Date:  2000-07       Impact factor: 4.709

Review 2.  The clinical implications of endothelial dysfunction.

Authors:  Michael E Widlansky; Noyan Gokce; John F Keaney; Joseph A Vita
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

Review 3.  Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques.

Authors:  D Tousoulis; C Antoniades; C Stefanadis
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

Review 4.  Microvascular rarefaction in hypertension--reversal or over-correction by treatment?

Authors:  Tarek Francis Antonios
Journal:  Am J Hypertens       Date:  2006-05       Impact factor: 2.689

Review 5.  Microcirculation and arterial hypertension.

Authors:  E Vicaut
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 6.  Endothelial dysfunction: a marker of atherosclerotic risk.

Authors:  Piero O Bonetti; Lilach O Lerman; Amir Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

7.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

Review 8.  New methods to evaluate endothelial function: method for assessing endothelial function in humans using a strain-gauge plethysmography: nitric oxide-dependent and -independent vasodilation.

Authors:  Yukihito Higashi; Masao Yoshizumi
Journal:  J Pharmacol Sci       Date:  2003-12       Impact factor: 3.337

9.  Structural skin capillary rarefaction in essential hypertension.

Authors:  T F Antonios; D R Singer; N D Markandu; P S Mortimer; G A MacGregor
Journal:  Hypertension       Date:  1999-04       Impact factor: 10.190

Review 10.  Smoking and hypertension as predictors of cardiovascular risk in population studies.

Authors:  W B Kannel; M Higgins
Journal:  J Hypertens Suppl       Date:  1990-09
View more
  14 in total

1.  Alterations in capillary morphology are found in mild blood pressure elevation.

Authors:  Cynthia Cheng; Constantine Daskalakis; Bonita Falkner
Journal:  J Hypertens       Date:  2010-11       Impact factor: 4.844

2.  Bone marrow mononuclear cell angiogenic competency is suppressed by a high-salt diet.

Authors:  Jamie R Karcher; Andrew S Greene
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-20       Impact factor: 4.249

3.  Non-invasive assessment of microvascular and endothelial function.

Authors:  Cynthia Cheng; Constantine Daskalakis; Bonita Falkner
Journal:  J Vis Exp       Date:  2013-01-29       Impact factor: 1.355

Review 4.  [Gender-specific differences in capillaroscopy in healthy persons and patients with inflammatory rheumatic diseases].

Authors:  J G Richter; P Klein-Weigel; R Brinks; M Schneider; O Sander
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

5.  Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients.

Authors:  Agnes Jumar; Joanna M Harazny; Christian Ott; Iris Kistner; Stefanie Friedrich; Roland E Schmieder
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-16       Impact factor: 3.738

6.  Capillary rarefaction: an early marker of microvascular disease in young hemodialysis patients.

Authors:  Alcia Edwards-Richards; Marissa DeFreitas; Chryso P Katsoufis; Wacharee Seeherunvong; Nao Sasaki; Michael Freundlich; Gaston Zilleruelo; Carolyn L Abitbol
Journal:  Clin Kidney J       Date:  2014-10-20

7.  Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus.

Authors:  Agnes Jumar; Joanna M Harazny; Christian Ott; Stefanie Friedrich; Iris Kistner; Kristina Striepe; Roland E Schmieder
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

8.  The superoxide dismutase mimetic tempol does not alleviate glucocorticoid-mediated rarefaction of rat skeletal muscle capillaries.

Authors:  Erin R Mandel; Emily C Dunford; Ghoncheh Abdifarkosh; Patrick C Turnbull; Christopher G R Perry; Michael C Riddell; Tara L Haas
Journal:  Physiol Rep       Date:  2017-05

9.  Assessing the impact of aging and blood pressure on dermal microvasculature by reactive hyperemia optical coherence tomography angiography.

Authors:  Michael Wang-Evers; Malte J Casper; Joshua Glahn; Tuanlian Luo; Abigail E Doyle; Daniel Karasik; Anne C Kim; Weeranut Phothong; Neera R Nathan; Tammy Heesakker; Garuna Kositratna; Dieter Manstein
Journal:  Sci Rep       Date:  2021-06-28       Impact factor: 4.379

10.  Association of Adipokines with Insulin Resistance, Microvascular Dysfunction, and Endothelial Dysfunction in Healthy Young Adults.

Authors:  Cynthia Cheng; Constantine Daskalakis
Journal:  Mediators Inflamm       Date:  2015-10-13       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.